|Articles|July 1, 2001

July 2001
Volume 7
Issue 7

Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts

Author(s)Bernard S. Bloom, PhD

Download PDF: Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts

Articles in this issue

almost 25 years ago

Article

Electronic Prescribing in Ambulatory Practice: Promises, Pitfalls, and Potential Solutions

almost 25 years ago

Article

Decomposing Pharmaceutical Cost Growth in Different Types of Health Plans

almost 25 years ago

Article

Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States

almost 25 years ago

Article

Promoting Smoking Abstinence in Pregnant and Postpartum Patients: A Comparison of Two Approaches

almost 25 years ago

Article

Primary Care Physician Job Satisfaction and Turnover

almost 25 years ago

Article

Physician Characteristics and the Initiation of Beta-Adrenergic Blocking Agent Therapy After Acute Myocardial Infarction in a Managed Care Population

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

Health care costs | Image Credit: © Valeri Luzina - stock.adobe.com

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

ByPooja Chandrashekar, MD, MBA,Sachin H. Jain, MD, MBA

June 4th 2026

Another Theory About Healthcare Expenditures and Inflation Refuted by the Facts

Articles in this issue

Related Content

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

What Do We Do With These Prices? Ushering in the Next Phase of Price Transparency Innovation in Medicare Advantage

Trending on AJMC

GLP-1 Therapies in 2026: Beyond Blood Sugar and the Scale

ACA Enrollment Erosion Deepens After Open Enrollment Ends

What ADA 2026 Data Reveal About the Growing Gap in Ketone Monitoring: Eden Miller, DO

Efgartigimod Effective in Broad Subsets of Patients With gMG

Alopecia Areata Takes a Hidden Toll on Work, Relationships, and Self-Care